CHI’s 5th Annual Immuno-Oncology Summit – Powering Next Generation Targeted Immunotherapies – saw record attendance! Over 550 delegates hailing from 26 countries gathered in Boston for a week-long summit of cutting-edge presentations by established Pharma & Biotech thought-leaders, top academics and researchers, and a collection of emerging scientists exploring next-generation breakthroughs in the burgeoning area of immuno-oncology. In addition to productive and energetic conference sessions, the exhibit hall also enjoyed record turnout, playing host to 36 exhibit booths and 39 poster presentations.
The Immuno-Oncology Summit At-A-Glance
Big Pharma: 17%
Healthcare Provider: 9%
Graeme E. Price, Ph.D.
Gene Transfer & Immunogenicity, FDA CBER
Gergana Zlateva, Ph.D.,
Payer Insights and Access, Oncology, Pfizer